Track the Canadian Junior Mining Market at the speed of AI

Build a portfolio of Canadian junior mining companies on 6ix and get real-time updates the minute they announce something. Discover investor events, company profiles, and news in one place.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
23h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Yesterday	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
Yesterday	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
Yesterday	Buffalo Potash Files Annual Information Form and New Technical Report
Yesterday	Ionik Announces 30-Day Extension of Senior Debt Facility

About

17.24USD-0.45 -2.54%

Closed • Updated at 13:18 GMT+00:00

Market Cap$1.78B

Volume2.80M

Beta-0.72

RSI51.85

Gross Margin98.50%

Health TechnologyPharmaceuticals: Major

Viridian Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350.0 Million

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑2 Clinical Trial in Chronic Thyroid Eye Disease

Viridian Therapeutics Announces Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial in Active Thyroid Eye Disease

Bambusa Therapeutics Appoints Todd James Chief Financial Officer

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results

Recent Videos

Viridian Therapeutics Prices $350M Offering

Viridian Therapeutics Prices $350M Offering

May 07, 2026

VRDN +41.0% — Viridian Therapeutics' Elegrobart Achieves Positive Phase 3 Results; Q1 Net Loss $1...

VRDN +41.0% — Viridian Therapeutics' Elegrobart Achieves Positive Phase 3 Results; Q1 Net Loss $1...

May 05, 2026

How to Invest in Viridian Therapeutics Inc (VRDN) Step by Step

How to Invest in Viridian Therapeutics Inc (VRDN) Step by Step

Apr 12, 2026

Viridian Therapeutics Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial

Viridian Therapeutics Positive Topline Results from Elegrobart Phase 3 REVEAL‑1 Clinical Trial

Apr 02, 2026

Community Chat

Ask AI

Try asking